Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

BioCryst Pharmaceuticals, Inc.

BCRX

Valuace

100

Růst

100

Zdraví

Cena

$ 9.30

-0.51 (-7.11%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Revenues	874.8	874.8	450.7	331.4	270.8	157.2	17.8	48.8	20.7	25.2	26.4	48.3	13.6	17.3	26.3	19.6	63.5
Cost of Revenues	19.8	19.1	12.5	4.7	6.6	7.3	1.7	4.1	0.5	1.7	2.7	1.9	0.1	0.1	0.1	0.0	0.1
Gross Profit	855.0	855.8	438.2	326.8	264.2	149.9	16.1	44.7	20.2	23.5	23.7	46.4	13.5	17.2	26.2	19.6	63.4

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	406.6	159.4	163.4	145.5	131.5	117.1	109.3	92.8	93.4	86.7
Cost of Revenues	9.9	2.5	2.8	4.6	6.1	3.2	1.7	1.3	2.1	1.1
Gross Profit	396.6	156.9	160.6	141.0	125.4	113.9	107.6	91.5	91.3	85.6

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
R&D Expenses	0.0	0.0	0.0	216.6	253.3	208.8	123.0	107.1	84.9	67.0	61.0	72.8	51.8	42.7	51.5	56.9	82.5
Selling General & Admin Expenses	0.0	0.0	0.0	213.9	159.4	118.8	67.9	37.1	29.5	13.9	11.3	13.0	7.5	5.2	6.8	12.3	14.2
Depreciation & Amortization	5.0	1.4	1.2	1.7	5.1	0.1	9.4	1.9	0.8	0.7	0.5	0.2	0.2	0.3	0.6	0.9	2.3
Total Operating Expenses	514.4	514.8	440.8	430.5	412.7	327.6	190.9	144.2	114.4	80.9	72.3	85.8	59.3	48.0	58.3	69.2	96.7
Operating Income	341.0	341.0	-2.5	-103.7	-148.4	-177.7	-174.8	-99.5	-94.2	-57.4	-48.6	-39.4	-45.8	-30.7	-33.9	-49.6	-33.2

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	46.9
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.4	50.6
Depreciation & Amortization	4.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.4
Total Operating Expenses	136.6	127.3	130.8	119.7	129.9	106.2	98.9	106.0	134.0	97.5
Operating Income	260.4	29.6	29.8	21.2	-4.5	7.7	8.8	-14.5	-42.7	-11.9

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Interest Income	10.7	10.7	14.7	15.8	5.1	0.1	9.4	1.9	2.3	1.0	0.8	0.5	0.1	0.1	0.2	0.4	0.5
Interest Expense	78.9	78.9	98.5	108.2	99.1	59.3	14.5	11.9	9.2	8.6	6.5	5.2	5.0	4.8	4.7	3.8	0.0
Other Expense	-73.6	-73.6	-84.4	-122.5	-95.9	-4.1	-8.1	-9.4	-0.1	-0.8	-0.8	1.1	5.5	5.3	-2.5	-4.0	503.5
IBT	267.4	267.4	-87.0	-226.2	-244.4	-181.8	-182.8	-108.9	-101.3	-65.8	-55.1	-43.0	-45.2	-30.1	-39.1	-56.9	-33,853.2
Income Tax Expense	3.5	3.5	1.9	0.3	2.7	2.3	13.8	11.2	2.1	7.9	6.0	5.0	4.8	4.5	4.0	6.5	500.8
Net Income	263.9	263.9	-88.9	-226.5	-247.1	-184.1	-196.6	-120.1	-101.3	-65.8	-55.1	-43.0	-45.2	-30.1	-39.1	-56.9	-32.7

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	2.9	2.2	2.5	3.0	3.6	3.6	3.6	4.0	4.5	4.2
Interest Expense	14.1	19.7	21.6	23.5	24.4	24.8	24.7	24.5	24.6	27.3
Other Expense	-12.4	-17.5	-23.3	-20.5	-21.5	-21.1	-21.3	-20.5	-20.5	-23.9
IBT	248.0	12.1	6.5	0.8	-26.0	-13.4	-12.5	-35.0	-63.2	-35.8
Income Tax Expense	2.2	-0.8	1.4	0.7	0.8	0.6	0.2	0.4	-1.4	0.3
Net Income	245.8	12.9	5.1	0.0	-26.8	-14.0	-12.7	-35.4	-61.7	-36.1

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
EPS	$0.00	$0.00	$0.00	$-1.18	$-1.38	$-1.03	$-1.18	$-1.04	$-0.98	$-0.78	$-0.75	$-0.59	$-0.68	$-0.55	$-0.79	$-1.26	$-0.73
EPS Diluted	$0.00	$0.00	$0.00	$-1.18	$-1.38	$-1.03	$-1.18	$-1.04	$-0.98	$-0.78	$-0.75	$-0.59	$-0.68	$-0.55	$-0.79	$-1.26	$-0.73
Shares Outstanding	211.0	209.9	206.7	192.2	179.1	179.1	167.3	115.6	103.2	84.5	73.7	72.9	66.8	55.2	49.5	45.1	44.6
Diluted Shares Outstanding	219.3	218.6	206.7	192.2	179.1	179.1	167.3	115.6	103.2	84.5	73.7	72.9	66.8	55.2	49.5	45.1	44.6

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.31	$-0.19
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.31	$-0.19
Shares Outstanding	211.0	210.2	209.5	208.9	207.4	206.9	206.4	206.1	201.4	189.6
Diluted Shares Outstanding	219.3	219.9	219.9	215.3	207.4	206.9	206.4	206.1	201.4	189.6

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Cash And Equivalents	80.2	104.9	110.6	304.8	504.4	272.1	114.2	26.7	50.3	22.1	28.9	54.5	21.2	20.9	16.4	13.6
Short Term Investments	193.6	216.1	278.3	119.5	3.2	28.2	22.1	77.7	64.1	32.5	22.7	18.2	16.9	14.7	25.3	40.3
Total Cash & ST Investments	273.8	321.1	389.0	442.4	514.4	300.4	136.2	126.8	155.7	63.6	99.2	113.9	40.6	36.8	41.7	53.9
Accounts Receivable	68.8	79.1	57.0	50.6	29.4	8.6	22.1	4.3	6.1	8.8	6.2	9.5	2.1	4.6	5.8	31.3
Inventory	4.5	8.1	28.7	27.5	15.8	7.0	1.6	1.6	-37.8	0.5	1.6	0.7	-2.4	-0.4	0.3	0.9
Other Current Assets	16.4	13.8	21.3	12.6	10.0	5.5	4.4	2.4	1.4	1.4	4.9	6.2	1.7	1.1	57.7	66.3
Total Current Assets	363.5	422.0	496.0	516.5	566.1	323.8	164.3	114.4	125.4	67.0	66.0	89.3	42.1	42.0	63.6	97.7

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	84.1	88.0	105.5	104.9	97.7	78.4	84.3	112.4	150.9	146.2
Short Term Investments	128.8	172.0	189.9	216.1	233.2	193.6	252.2	278.3	246.7	267.9
Total Cash & ST Investments	212.9	260.0	295.4	321.1	330.8	272.0	336.6	390.8	397.6	414.1
Accounts Receivable	91.3	91.2	93.4	79.1	72.5	68.8	60.6	57.0	53.6	57.7
Inventory	5.2	5.0	6.9	8.1	7.6	4.5	29.8	28.7	29.6	27.0
Other Current Assets	46.3	42.2	14.3	13.8	16.3	18.2	20.2	21.3	21.6	15.7
Total Current Assets	355.7	398.5	410.0	422.0	427.1	363.5	447.1	496.0	397.6	414.1

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Property, Plant & Equipment	20.1	19.8	20.9	15.4	8.7	7.1	7.3	9.1	9.5	9.9	5.1	0.2	0.3	0.6	1.1	1.9
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	64.3	21.7	0.0	18.1	6.8	0.0	0.0	22.4	41.3	8.9	47.7	41.1	2.6	1.2	15.4	11.8
Other Long-Term Assets	24.5	26.9	0.1	0.0	6.5	3.8	3.6	1.0	2.0	4.0	5.7	6.2	3.9	13.7	2.2	-0.8
Total Long-Term Assets	109.0	68.5	21.0	33.5	22.0	10.9	10.9	32.5	52.9	22.9	58.6	47.5	6.7	15.5	18.7	12.9
Total Assets	472.4	490.4	517.0	550.0	588.2	334.7	175.3	146.8	178.3	89.8	124.6	136.9	48.9	57.4	82.2	110.6

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	19.2	20.0	19.6	19.8	23.1	7.7	7.8	21.0	9.0	8.4
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	39.7	10.1	21.9	21.7	19.4	64.3	0.0	0.0	0.0	3.4
Other Long-Term Assets	31.8	28.6	28.5	26.9	21.6	37.0	13.0	0.0	11.5	6.9
Total Long-Term Assets	90.7	58.7	70.1	68.5	64.1	109.0	20.8	21.0	20.5	18.8
Total Assets	446.4	457.2	480.0	490.4	491.3	472.4	467.9	517.0	-685.5	529.9

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Accounts Payable	7.8	11.6	20.9	14.4	27.8	18.7	14.0	7.8	6.3	4.3	9.3	2.8	4.2	4.0	2.5	8.2
Short-Term Debt	31.7	35.4	2.6	2.4	1.8	31.2	40.0	33.7	35.2	28.2	30.0	30.0	0.0	0.0	0.0	0.0
Other Current Liabilities	89.6	113.3	126.4	87.6	72.7	55.6	36.3	27.7	24.8	19.8	23.0	17.8	9.6	11.9	14.0	17.1
Current Liabilities	129.1	160.4	150.0	105.5	103.7	105.7	92.3	69.5	74.8	54.4	64.5	57.7	15.3	17.2	26.3	27.8

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	5.6	8.6	10.0	11.6	13.5	7.8	11.9	20.9	10.6	13.9
Short-Term Debt	39.5	2.0	37.2	35.4	35.9	2.7	2.7	2.6	2.3	2.5
Other Current Liabilities	145.2	166.6	92.6	113.3	104.2	118.6	105.3	126.4	77.4	75.3
Current Liabilities	190.2	177.2	139.9	160.4	153.6	129.1	119.9	150.0	90.8	93.5

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Long-Term Debt	808.5	806.0	822.5	739.1	591.4	124.7	44.7	28.1	19.5	25.5	2.4	0.0	30.0	30.0	30.0	0.0
Capital Leases	10.5	0.0	11.2	8.2	7.8	124.7	4.8	2.8	2.8	2.7	2.4	0.0	0.0	0.0	0.0	0.0
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-2.7	-2.4	0.0	0.0	0.0	-7.1	0.0
Total Liabilities	948.0	966.4	972.5	844.6	695.1	354.0	137.0	97.6	94.5	88.3	76.8	61.2	50.0	57.9	67.4	43.9

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	643.6	701.2	792.1	806.0	806.3	819.0	824.1	822.5	843.1	825.1
Capital Leases	12.0	12.5	0.0	0.0	0.0	13.2	13.8	11.2	10.0	5.8
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	834.3	878.8	932.0	966.4	959.8	948.0	944.1	972.5	933.9	918.6

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Common Stock	2.1	2.1	2.1	1.9	1.8	1.8	1.5	1.1	1.0	0.7	0.7	0.7	0.6	0.5	0.5	0.4
Retained Earnings	-1,729.2	-1,770.0	-1,681.2	-1,454.6	-1,207.5	-1,023.4	-840.6	-732.0	-631.8	-566.1	-510.9	-467.9	-422.7	-392.6	-353.5	-295.5
Comprehensive Income	0.6	0.9	1.3	0.0	0.2	0.0	0.0	-0.3	-0.2	0.0	-0.2	-0.1	0.0	0.0	0.0	0.1
Total Common Equity	-475.6	-475.9	-455.5	-1,454.6	-1,207.5	-1,023.4	-840.6	-732.0	83.8	1.6	47.7	75.6	-1.1	-0.5	14.8	66.6

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	2.1	2.1	2.1	2.1	2.1	2.1	2.1	2.1	1.9	1.9
Retained Earnings	-1,752.0	-1,764.9	-1,770.0	-1,770.0	-1,743.2	-1,729.2	-1,716.5	-1,681.2	-1,619.4	-1,583.3
Comprehensive Income	1.1	1.6	1.1	0.9	2.3	0.6	0.8	1.3	0.8	0.7
Total Common Equity	-387.9	-421.6	-451.9	-475.9	-468.6	-475.6	-476.2	-455.5	-1,619.4	-1,583.3

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Debt		850.6	841.4	848.7	741.5	593.2	124.7	84.7	61.8	54.7	53.7	32.4	30.0	30.0	30.0	30.0	0.0
Book Value		-475.6	-475.9	-455.5	-294.6	-107.0	-19.3	38.3	49.2	83.8	1.6	47.7	75.6	-1.1	-0.5	14.8	66.6

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		-387.9	-421.6	-451.9	-475.9	-468.6	-475.6	-476.2	-455.5	-1,619.4	-1,583.3

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Income	-145.9	263.9	-88.9	-226.5	-247.1	-184.1	-182.8	-108.9	-101.3	-65.8	-55.1	-43.0	-45.2	-30.1	-39.1	-56.9	-33.9
Depreciation & Amortization	1.5	1.4	1.2	1.7	1.4	0.8	0.7	0.7	0.8	0.7	0.5	0.2	0.2	0.3	0.6	0.9	2.3
Stock-Based Compensation	55.6	0.0	65.4	55.6	44.7	34.6	14.8	17.7	9.4	12.6	8.5	9.7	10.2	4.4	4.2	4.8	6.3
Change Working Capital	-64.9	-56.9	-87.3	-32.4	-58.9	8.1	26.9	-0.9	-3.5	9.3	-7.6	19.0	1.3	3.8	-4.3	14.7	-3.3
Change In Accounts Receivable	-11.2	-36.8	-22.7	-6.1	-21.5	-23.8	18.5	-16.2	0.6	2.7	-2.5	-7.4	-7.4	2.4	1.3	25.0	9,424.9
Change In Accounts Payable	-52.5	57.8	-62.4	-16.8	-22.4	39.4	17.4	11.7	4.5	3.8	-10.5	6.8	6.8	-2.0	2.1	-10.7	-9,431.0
Change In Inventories	-3.0	-1.6	-4.2	-1.5	-12.4	-8.8	-7.0	1.6	-1.6	0.5	1.1	-0.9	-0.7	-0.6	0.3	0.6	5.4
Other Non-cash Items	118.8	121.5	57.5	106.5	98.1	54.2	2.4	1.3	0.9	0.9	0.6	0.4	0.4	0.4	0.4	4.0	0.0
Cash from Operations	-84.3	0.0	0.0	-95.1	-161.9	-142.2	-137.2	-89.6	-92.6	-41.1	-53.4	-13.1	-38.6	-26.5	-37.4	-32.3	-28.6

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	362.3	12.9	5.1	0.0	-26.8	-14.0	-12.7	-35.4	-61.7	-36.1
Depreciation & Amortization	4.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.4
Stock-Based Compensation	72.6	0.0	21.3	21.4	21.3	17.2	13.2	13.7	16.5	12.3
Change Working Capital	4.2	-1.4	2.4	-62.1	-11.3	-9.1	-18.3	-48.5	18.1	-16.2
Change In Accounts Receivable	-15.5	0.0	-7.3	-14.0	-7.3	-3.3	-8.2	-3.8	-3.0	3.8
Change In Accounts Payable	35.4	24.6	45.0	-47.1	-2.4	0.0	0.0	0.0	19.9	-15.3
Change In Inventories	-0.5	-1.7	1.4	-0.9	-2.2	-1.5	0.7	-1.2	0.9	-3.4
Other Non-cash Items	-167.1	29.2	12.2	12.9	11.3	13.9	16.1	16.3	17.3	32.5
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-8.9	-19.9

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Capital Expenditure	-1.9	-2.5	-1.1	-2.2	-1.4	-2.4	-0.5	-0.3	-0.4	-0.3	-5.3	-5.1	-0.1	0.0	-0.1	-0.1	-0.3
Acquisitions	-18.7	-6.2	0.0	0.0	1.4	2.4	0.5	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	324.8
Investments	-481.2	-262.2	-266.8	-514.4	-244.3	-10.0	-49.8	-3.0	-62.6	-107.8	-14.1	-53.8	-73.9	-24.0	-16.2	-45.5	-55.9
Sales of Investment	504.1	256.6	320.5	385.1	117.4	28.2	43.5	81.3	67.7	43.5	42.7	42.4	34.0	20.3	40.8	56.9	56.5
Other Investing Activities	21.6	0.0	0.0	0.0	-1.4	-2.4	-0.5	-0.4	-0.4	-1.7	0.1	-1.5	0.0	0.2	0.3	-0.1	-324.8
Cash from Investing	21.0	0.0	0.0	-131.5	-128.2	15.8	-6.9	77.9	4.8	-66.4	23.3	-18.0	-40.0	-3.5	24.9	11.3	0.2

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	-0.8	-1.3	-0.2	-0.1	-0.7	-0.1	-0.2	-0.2	-0.6	-1.0
Acquisitions	-6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	-24.1
Investments	-125.5	-58.6	-29.3	-48.8	-39.5	-26.9	-112.3	-88.0	-157.0	-123.9
Sales of Investment	49.0	73.0	58.6	76.0	58.0	35.5	110.0	117.0	129.1	148.0
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-28.5	23.1

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Debt Repaid	-2.2	0.0	0.0	27.1	0.0	0.0	-52.4	0.0	-4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	847.1	841.4	-7.3	134.4	148.2	468.5	92.5	22.8	11.1	1.0	21.3	2.4	30.0	30.0	30.0	30.0	0.0
Issuance of Common Stock	1.9	0.0	0.0	0.3	15.0	50.0	93.3	58.5	53.4	134.0	0.3	0.0	106.6	23.6	17.8	1.3	0.3
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-0.1	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	-6.6	0.0	0.0	5.0	73.1	309.7	261.8	40.6	13.1	1.7	23.0	5.5	5.3	6.6	-0.8	22.5	0.6
Cash from Financing	-4.6	0.0	0.0	32.5	88.0	359.7	302.7	99.1	62.5	135.7	23.3	5.5	111.9	30.3	17.0	23.8	0.8

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-1.2	0.0
Debt Issued	683.1	-20.1	-126.1	-12.1	-0.7	20.5	-5.2	-21.8	839.9	4.2
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-2.0	1.2
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-3.2	1.2

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Change in Cash		-67.6	-103.3	-6.1	-193.8	-201.5	233.4	158.6	87.4	-25.3	28.2	-6.8	-25.6	33.4	0.3	4.4	2.8	-27.5
Closing Cash Balance		80.2	1.6	106.3	112.4	306.2	507.7	274.3	115.7	28.3	50.3	22.1	28.9	54.5	21.2	20.9	16.4	13.6

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		-83.1	-3.9	-17.0	0.6	7.3	18.9	-5.9	-26.3	-40.0	4.7
Closing Cash Balance		1.6	84.7	89.9	106.9	106.3	99.1	80.2	86.1	112.4	152.5

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Free Cash Flow		-86.2	327.4	-53.1	-97.3	-163.2	-144.5	-137.7	-89.9	-92.9	-41.5	-58.7	-18.2	-38.7	-26.6	-37.5	-32.3	-28.9
Real Free Cash Flow		-141.8	327.4	-118.6	-152.9	-207.9	-179.2	-152.5	-107.6	-102.3	-54.1	-67.2	-27.9	-48.8	-30.9	-41.7	-37.1	-35.2

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		275.2	39.8	41.1	-27.7	-5.9	8.2	-1.5	-53.9	-9.5	-20.9
Real Free Cash Flow		202.7	39.8	19.8	-49.0	-27.2	-9.1	-14.7	-67.6	-26.0	-33.2